SFM
OKUR

Sphera Funds Management’s OnKure Therapeutics OKUR Stock Holding History

Sphera Funds Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,454
Closed -$175K – 120
2025
Q4 		$175K Hold
60,454
– – 0.03% 96
2025
Q3 		$166K Hold
60,454
– – 0.04% 110
2025
Q2 		$144K Sell
60,454
-20,000
-25% -$52.4K 0.03% 106
2025
Q1 		$346K Sell
80,454
-6,900
-8% -$38.8K 0.08% 108
2024
Q4 		$751K Buy
+87,354
New +$1.32M 0.14% 97

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sphera Funds Management's OKUR Position: Q1 2026 in Review

Sphera Funds Management sold out of OnKure Therapeutics (OKUR) in Q1 2026, closing a stake of 60,454 shares — an estimated $175K sold.

Sphera Funds Management first reported a position in OKUR in Q4 2024 and held it in 5 quarters. The position peaked at $751K in Q4 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Sphera Funds Management reported no remaining OnKure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Sphera Funds Management sold 60,454 OnKure Therapeutics shares in Q1 2026, an estimated $175K.
  • Sphera Funds Management first reported a position in OnKure Therapeutics in Q4 2024 and held it in 5 quarters.
  • Sphera Funds Management's OnKure Therapeutics position peaked at $751K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.